Medical and Physiological Benefits of Reduced Sitting
1 other identifier
interventional
64
1 country
1
Brief Summary
The most important objective of this randomized controlled trial in subjects with increased cardiovascular and metabolic risk factors is to investigate whether only reduced daily sitting improves human cardiovascular and metabolic health during a six-month intervention. It is hypothesized and expected that only reduced sitting, without formal physical activity or exercise training, affects favorably cardiovascular and metabolic health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2017
CompletedFirst Posted
Study publicly available on registry
April 5, 2017
CompletedStudy Start
First participant enrolled
April 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 14, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 4, 2020
CompletedApril 8, 2020
April 1, 2020
2.8 years
March 24, 2017
April 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The change in whole-body insulin sensitivity
M-value during the hyperinsulinemic euglycemic clamp
The change from baseline to 6 months
The change in skeletal muscle insulin-stimulated glucose uptake
Glucose uptake in the femoral muscles will be measured by positron emission tomography (PET) with \[18F\]-labelled fluoro-deoxy-glucose (FDG) tracer during hyperinsulinemic euglycemic clamp
The change from baseline to 6 months
Secondary Outcomes (10)
daily sitting hours
through study completion, an average of 6 months
daily hours spent physically active
through study completion, an average of 6 months
The change in liver adiposity
The change from baseline to 6 months
The change in maximal oxygen uptake
The change from baseline to 6 months
The change in body fat percentage
The change from baseline to 3 months
- +5 more secondary outcomes
Study Arms (2)
Reduced sitting
EXPERIMENTALObjectively measured daily inactive time will be reduced by one hour compared to the baseline.
Control
NO INTERVENTIONSubjects will be guided to maintain their normal sedentary behaviour and physical activity habits.
Interventions
Subjects are guided to limit their sitting time during the day for 1 hour/day, by adding light activity with the help of an activity monitor. Subjects are not encouraged to increase their moderate to vigorous physical activity levels.
Eligibility Criteria
You may qualify if:
- Physically inactive (less than 120 minutes of moderate intensity exercise per week measured by the activity monitor during run-in)
- Sitting time ≥ 10 h /day (measured by the activity monitor during run-in)
- BMI 25-40
- Blood pressure \< 160/100 mmHg
- Fasting plasma glucose \< 7.0 mmol/l
- Fulfills the criteria of the metabolic syndrome according to Alberti et al 2009
You may not qualify if:
- History of a cardiac event
- Insulin or medically treated diabetes
- Any chronic disease or condition that could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results
- Presence of ferromagnetic objects that would make MR imaging contraindicated
- Abundant use of alcohol
- Use of narcotics
- Smoking of tobacco or consuming snuff tobacco
- Diagnosed depressive or bipolar disorder
- Previous PET imaging or considerable exposure to radiation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Turku University Hospitallead
- UKK Institutecollaborator
Study Sites (1)
Turku PET Centre
Turku, 20521, Finland
Related Publications (8)
Norha J, Sjoros T, Garthwaite T, Laine S, Laitinen K, Houttu N, Vaha-Ypya H, Sievanen H, Loyttyniemi E, Vasankari T, Knuuti J, Kalliokoski KK, Heinonen IHA. Secondary analysis of a randomised controlled trial on reducing sedentary behaviour and its effects on quality of life and wellbeing. Sci Rep. 2025 Oct 22;15(1):36861. doi: 10.1038/s41598-025-20836-7.
PMID: 41125692DERIVEDGarthwaite T, Sjoros T, Laine S, Koivumaki M, Vaha-Ypya H, Norha J, Kallio P, Saarenhovi M, Loyttyniemi E, Sievanen H, Houttu N, Laitinen K, Kalliokoski KK, Vasankari T, Knuuti J, Heinonen I. Successfully Reducing Sitting Time Can Improve Metabolic Flexibility. Scand J Med Sci Sports. 2025 Aug;35(8):e70113. doi: 10.1111/sms.70113.
PMID: 40781908DERIVEDYlinen VP, Sjoros T, Laine S, Garthwaite T, Norha J, Vaha-Ypya H, Loyttyniemi E, Houttu N, Laitinen K, Kalliokoski KK, Sievanen H, Vasankari T, Knuuti J, Heinonen IH. Sedentary behavior reduction and blood lipids in adults with metabolic syndrome: a 6-month randomized controlled trial. Sci Rep. 2024 Oct 16;14(1):24241. doi: 10.1038/s41598-024-75579-8.
PMID: 39414998DERIVEDNorha J, Sjoros T, Garthwaite T, Laine S, Verho T, Saunavaara V, Laitinen K, Houttu N, Hirvonen J, Vaha-Ypya H, Sievanen H, Loyttyniemi E, Vasankari T, Kalliokoski K, Heinonen I. Effects of reducing sedentary behaviour on back pain, paraspinal muscle insulin sensitivity and muscle fat fraction and their associations: a secondary analysis of a 6-month randomised controlled trial. BMJ Open. 2024 Sep 28;14(9):e084305. doi: 10.1136/bmjopen-2024-084305.
PMID: 39343453DERIVEDSjoros T, Norha J, Johansson R, Laine S, Garthwaite T, Vaha-Ypya H, Loyttyniemi E, Kalliokoski KK, Sievanen H, Vasankari T, Knuuti J, Heinonen IHA. Tiredness after work associates with less leisure-time physical activity. Sci Rep. 2024 Apr 4;14(1):7965. doi: 10.1038/s41598-024-58775-4.
PMID: 38575674DERIVEDSjoros T, Laine S, Garthwaite T, Vaha-Ypya H, Loyttyniemi E, Koivumaki M, Houttu N, Laitinen K, Kalliokoski KK, Sievanen H, Vasankari T, Knuuti J, Heinonen IHA. Reducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial. Med Sci Sports Exerc. 2023 Mar 1;55(3):342-353. doi: 10.1249/MSS.0000000000003054. Epub 2022 Oct 13.
PMID: 36251378DERIVEDNorha J, Hautala AJ, Sjoros T, Laine S, Garthwaite T, Knuuti J, Loyttyniemi E, Vaha-Ypya H, Sievanen H, Vasankari T, Heinonen IHA. Standing time and daily proportion of sedentary time are associated with pain-related disability in a one month accelerometer measurement in adults with overweight or obesity. Scand J Pain. 2021 Sep 27;22(2):317-324. doi: 10.1515/sjpain-2021-0108. Print 2022 Apr 26.
PMID: 34582633DERIVEDSjoros T, Vaha-Ypya H, Laine S, Garthwaite T, Lahesmaa M, Laurila SM, Latva-Rasku A, Savolainen A, Miikkulainen A, Loyttyniemi E, Sievanen H, Kalliokoski KK, Knuuti J, Vasankari T, Heinonen IHA. Both sedentary time and physical activity are associated with cardiometabolic health in overweight adults in a 1 month accelerometer measurement. Sci Rep. 2020 Nov 25;10(1):20578. doi: 10.1038/s41598-020-77637-3.
PMID: 33239818DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Juhani Knuuti, Professor
Turku PET Centre, Turku University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the intervention, masking of the participants is not possible. Analyzing of the obtained data will be masked.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 24, 2017
First Posted
April 5, 2017
Study Start
April 25, 2017
Primary Completion
February 14, 2020
Study Completion
March 4, 2020
Last Updated
April 8, 2020
Record last verified: 2020-04